The current stock price of AKRX is 0.09 null. In the past month the price decreased by -57.14%. In the past year, price decreased by -97.82%.
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.
Akorn Inc
1925 WEST FIELD COURT SUITE 300
LAKE FOREST IL 60045
CEO: Douglas S. Boothe
Phone: 847-279-6100
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.
The current stock price of AKRX is 0.09 null. The price decreased by -51.01% in the last trading session.
AKRX does not pay a dividend.
AKRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Akorn Inc (AKRX) has a market capitalization of 11.98M null. This makes AKRX a Nano Cap stock.
ChartMill assigns a fundamental rating of 4 / 10 to AKRX. While AKRX is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months AKRX reported a non-GAAP Earnings per Share(EPS) of 0.14000000000000004. The EPS increased by 122.58% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -55.64% | ||
| ROA | -38.88% | ||
| ROE | N/A | ||
| Debt/Equity | -1.1 |